Daewoong and Kwangdong Pharmaceutical announced a treasury share swap worth over $40 million to forge a strategic partnership, aiming to boost collaboration in R&D, sales, and overseas expansion, while Kwangdong also strengthens ties with Huons Meditech and Dongwon Systems.
#YonhapInfomax #Daewoong #KwangdongPharmaceutical #TreasuryShareSwap #StrategicPartnership #ShareCancellation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=96898

Daewoong Co., Ltd. will sell 581,420 treasury shares worth 13.8 billion won ($10.6 million) to Kwangdong Pharmaceutical to strengthen their strategic partnership.
#YonhapInfomax #Daewoong #KwangdongPharmaceutical #TreasuryShares #StrategicPartnership #138BillionWon #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=96895

Daewoong Co., Ltd. has been selected for a national R&D project to develop digital twin-based next-generation biopharmaceutical manufacturing processes, aiming to enhance automation and quality in production.
#YonhapInfomax #Daewoong #DigitalTwin #Biopharmaceutical #ManufacturingProcess #RDProject #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=74041

Daewoong Co.'s treasury shares approach 30%, the highest in South Korea's pharma sector, raising concerns among experts about governance risks and shareholder value dilution.
#YonhapInfomax #Daewoong #TreasuryShares #ShareholderValue #CorporateGovernance #PharmaceuticalSector #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=69408